Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Fu Lin

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Oncotarget|November 9, 2017
Maternal and fetal outcomes of pregnant women with type 1 diabetes, a national population studyShu-Fu Lin, Chang-Fu Kuo, Meng-Jiun Chiou, et al.
Human Gene Therapy|February 27, 2014
Epithelial-mesenchymal transition enhances response to oncolytic herpesviral therapy through nectin-1Chun-Hao Chen, Wei-Yi Chen, Shu-Fu Lin, et al.
Frontiers in Endocrinology|March 18, 2022
Risk Factors and Prognosis for Metastatic Follicular Thyroid CancerMing-Hsien Wu, Yi-Yin Lee, Yu-Ling Lu, et al.
Experimental and Therapeutic Medicine|June 28, 2016
Study of TCM clinical records based on LSA and LDA SHTDT modelFan Lin, Zhihong Zhang, Shu-Fu Lin, et al.
Oncotarget|October 6, 2017
Effects of roniciclib in preclinical models of anaplastic thyroid cancerShu-Fu Lin, Jen-Der Lin, Chuen Hsueh, et al.
Cancers|February 13, 2025
Targeting Ataxia Telangiectasia-Mutated and Rad3-Related for Anaplastic Thyroid CancerShu-Fu Lin, Chuen Hsueh, Wei-Yi Chen, et al.
Plos One|February 17, 2017
A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancerShu-Fu Lin, Jen-Der Lin, Chuen Hsueh, et al.
Oncotarget|July 3, 2018
Activity of roniciclib in medullary thyroid cancerShu-Fu Lin, Jen-Der Lin, Chuen Hsueh, et al.
Endocrine-Related Cancer|June 14, 2018
Potent effects of roniciclib alone and with sorafenib against well-differentiated thyroid cancerShu-Fu Lin, Jen-Der Lin, Chuen Hsueh, et al.
Endocrine-Related Cancer|July 21, 2025
DNA-PKcs inhibition as a therapeutic approach for differentiated thyroid cancerShu-Fu Lin, Wei-Yi Chen, Chuen Hsueh, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Oncotarget|November 9, 2017
Maternal and fetal outcomes of pregnant women with type 1 diabetes, a national population studyShu-Fu Lin, Chang-Fu Kuo, Meng-Jiun Chiou, et al.
Human Gene Therapy|February 27, 2014
Epithelial-mesenchymal transition enhances response to oncolytic herpesviral therapy through nectin-1Chun-Hao Chen, Wei-Yi Chen, Shu-Fu Lin, et al.
Frontiers in Endocrinology|March 18, 2022
Risk Factors and Prognosis for Metastatic Follicular Thyroid CancerMing-Hsien Wu, Yi-Yin Lee, Yu-Ling Lu, et al.
Experimental and Therapeutic Medicine|June 28, 2016
Study of TCM clinical records based on LSA and LDA SHTDT modelFan Lin, Zhihong Zhang, Shu-Fu Lin, et al.
Oncotarget|October 6, 2017
Effects of roniciclib in preclinical models of anaplastic thyroid cancerShu-Fu Lin, Jen-Der Lin, Chuen Hsueh, et al.
Cancers|February 13, 2025
Targeting Ataxia Telangiectasia-Mutated and Rad3-Related for Anaplastic Thyroid CancerShu-Fu Lin, Chuen Hsueh, Wei-Yi Chen, et al.
Plos One|February 17, 2017
A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancerShu-Fu Lin, Jen-Der Lin, Chuen Hsueh, et al.
Oncotarget|July 3, 2018
Activity of roniciclib in medullary thyroid cancerShu-Fu Lin, Jen-Der Lin, Chuen Hsueh, et al.
Endocrine-Related Cancer|June 14, 2018
Potent effects of roniciclib alone and with sorafenib against well-differentiated thyroid cancerShu-Fu Lin, Jen-Der Lin, Chuen Hsueh, et al.
Endocrine-Related Cancer|July 21, 2025
DNA-PKcs inhibition as a therapeutic approach for differentiated thyroid cancerShu-Fu Lin, Wei-Yi Chen, Chuen Hsueh, et al.
Pageof 5